Creating a tumor bank for blood samples from cancer patients and healthy controls

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to establish a tumor bank that collects blood samples from patients with various types of cancer, including ovarian, breast, colorectal, and lung neoplasms, as well as healthy individuals for comparison. The collected samples will be accompanied by corresponding clinical data to facilitate future research in cancer diagnosis and treatment. By systematically gathering these biological samples, the study seeks to enhance translational oncology efforts, bridging laboratory findings with clinical applications to improve patient outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male/Female
* Age 18 to 90 years max.
* Just one current known malignant disease or
* Just one current inflammatory disease

Exclusion Criteria:

* Inflammatory disease and malignant disease
* multiple malignancies
* multiple diseases
* underage

Where it's running

• Charité University - Campus Virchow Chlinic
  Berlin, Germany Recruiting
• Innsbruck Medical University
  Innsbruck, Austria Completed
• University Hospitals Leuven - Department of Obstetrics and Gynaecology
  Leuven, Belgium Completed
• University Medical Center Freiburg
  Freiburg im Breisgau, Germany Completed
• University Clinic of Ruhr University Bochum
  Herne, Germany Completed
• European Institute of Oncology, Division of Gynecologic Oncology, Unit of Preventive Gynecology
  Milan, Italy Withdrawn

Study contacts

• Principal investigator: Robert Zeillinger, Prof.Dr. — Medical University Vienna, Dept. of Obstetrics & Gynaecology
• Study coordinator: Robert Zeillinger, Prof. Dr.
• Email: robert.zeillinger@meduniwien.ac.at
• Phone: +43140400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Creating a bank of tumor tissue samples for research

  This study is creating a collection of tumor tissue samples from cancer patients and healthy individuals to help researchers find better ways to diagnose and treat cancer.

  Recruiting Medical University of Vienna · Vienna and 2 other locations · NCT01789229

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• LY4337713 for people with FAP-positive ovarian, breast, pancreatic, colorectal, or esophageal cancers

  This trial tests LY4337713, a FAP-targeted lutetium-177 therapy, in people with advanced cancers that show high levels of fibroblast activation protein (FAP).

  Recruiting at 17 sites Phase 1 Eli Lilly and Company · Newport Beach, California and 29 other locations · NCT07213791

• High-sensitivity blood test to detect and monitor multiple cancers

  This study will test a high-sensitivity blood test that looks for tumor DNA to detect and follow several common cancers in adults with those cancers or people having routine health screenings.

  Recruiting Yonsei University · Seoul · NCT07035587

• Benchmarking AI language models against tumor boards for oncology treatment decisions

  This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.

  Recruiting Assistance Publique - Hôpitaux de Paris · Boulogne-Billancourt and 4 other locations · NCT07739121

• Dabrafenib and trametinib for rare cancers with BRAF V600 mutations

  This arm tests whether dabrafenib and trametinib can help adults, children, and teens with cancers that have a BRAF V600 mutation.

  Recruiting at 15 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT07440290

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.